Patent · US Active

Solid forms of an ASK1 inhibitor

US9907790B2 · kind B2 · utility

5Cited by
2References
10Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 6, 2017
Grant dateMar 6, 2018
Priority date—
Expiry dateApr 6, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Crystalline forms of 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide (Compound I) were prepared and characterized in the solid state:Also provided are processes of manufacture and methods of using the crystalline forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.